Professional Overview

Prof. Atanas G. Atanasov is a globally recognized biomedical scientist, digital health innovator, and strategic scientific advisor available for consultancy engagements across research evaluation, investment due diligence, advisory board service, and digital visibility campaigns. He holds the Chair of Pharmacology and leads the Patient Safety & Digital Health (PaDiH) Group at Danube Private University and the Ludwig Boltzmann Institute Digital Health and Patient Safety (LBI-DHPS), Medical University of Vienna. He is concurrently Professor at the Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences (IGAB PAS), Honorary Fellow of the International Lipid Expert Panel (ILEP) and Saveetha Institute of Medical and Technical Sciences (SIMATS), and serves as Editor-in-Chief of multiple international peer-reviewed journals.

With 350+ peer-reviewed publications, Clarivate Cross-Field Highly Cited Researcher status (2021–2023), and ranking among the World’s Top 2% Scientists (Stanford/Elsevier/Scopus), Prof. Atanasov brings exceptional scientific credibility to every engagement. He accepts select mandates from grant agencies, venture capital firms, biotechnology companies, professional associations, and health innovation organizations seeking rigorous scientific judgment, strategic positioning, and authoritative thought leadership.

Consultancy & Advisory Engagements

1. Review of Research Proposals & Grant Applications

Prof. Atanasov provides expert review and scoring of research proposals for funding agencies, foundations, innovation programs, and government bodies. His extensive experience as both principal investigator and panel evaluator makes him an ideal reviewer for:

National and international research grant competitions (e.g., Horizon Europe, NIH-style panels, national science foundations)
Biomedical, pharmacological, and digital health project portfolios
Health technology assessment (HTA) submissions
Innovation challenge and accelerator program applications
Industry-funded research and consortium proposals

He offers written evaluation reports, scoring, and panel participation in both English and German.

2. Scientific Due Diligence & Investment Evaluation

Prof. Atanasov is available to life sciences investors, venture capital firms, private equity groups, family offices, and corporate M&A teams requiring rigorous scientific evaluation of:

Pre-clinical and clinical-stage biotech and pharma assets
Digital health platforms and AI-driven healthcare products
Nutraceutical, functional food, and consumer health claims
Startup scientific credibility and IP defensibility
Technology readiness level (TRL) and translational potential
Competitive scientific landscape analysis

He delivers concise, actionable due diligence reports and is available for investor calls and pitch evaluations.

3. Scientific Advisory Board (SAB) & Board Memberships

Prof. Atanasov is open to serving on Scientific Advisory Boards (SABs), Independent Expert Committees, and Non-Executive Boards for:

Biotechnology and pharmaceutical startups and scale-ups
Digital health and healthtech companies
Academic spin-offs and technology transfer organizations
Professional medical and scientific associations
Health innovation hubs, clusters, and public-private consortia

He brings cross-disciplinary expertise in pharmacology, molecular medicine, digital health, and research strategy — providing both strategic guidance and scientific credibility to organizations and their stakeholders.

4. Digital Visibility & Science Communication Campaigns

With a combined following exceeding 165,000 professionals on LinkedIn, X (formerly Twitter), and Bluesky, Prof. Atanasov offers sponsored science communication partnerships to organizations seeking authentic reach within global scientific, clinical, and health innovation communities. Available formats include:

Sponsored educational content series (written, video, or live)
Science ambassador and brand spokesperson roles
LinkedIn thought leadership articles and newsletter features
Conference and event digital promotion campaigns
Co-branded webinars and expert Q&A sessions
Research and product awareness campaigns targeting scientists, clinicians, and investors

All campaigns are grounded in evidence-based communication and are clearly disclosed as partnerships, maintaining audience trust.

5. Expert Witness, Report Writing & Regulatory Consulting

Prof. Atanasov is available to legal firms, regulatory consultancies, and healthcare companies requiring authoritative scientific expert opinions for:

Expert witness statements in litigation involving health technologies, supplements, or pharmaceuticals
Regulatory dossier review and scientific substantiation (EU, US, global)
Health claim validation and evidence gap analysis
Scientific advisory reports for IP disputes

6. Keynote Speaking & Executive Education

Prof. Atanasov is a sought-after international keynote speaker and workshop facilitator for conferences, corporate events, executive retreats, and innovation forums. His keynote topics include:

Digital health transformation and AI in healthcare
Scientific credibility and evidence evaluation in health innovation
Translational biotechnology: from bench to market
Research impact, visibility, and thought leadership strategies
Innovation ecosystems and open science

He delivers tailored presentations for scientific, clinical, executive, and investor audiences and accepts engagements globally.

Scientific Credentials & Recognition

350+ peer-reviewed publications in leading international journals
Clarivate Web of Science Cross-Field Highly Cited Researcher (2021, 2022, 2023)
Stanford/Elsevier/Scopus World’s Top 2% Scientists
Chair of Pharmacology, Danube Private University
Research Group Leader, Ludwig Boltzmann Institute Digital Health and Patient Safety (LBI-DHPS), Medical University of Vienna
Professor, Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences (IGAB PAS)
Honorary Fellow, International Lipid Expert Panel (ILEP)
Honorary Fellow, Saveetha Institute of Medical and Technical Sciences (SIMATS)
Editor-in-Chief, multiple indexed international scientific journals
Author: Health Hacks That Work: 50 Practical, Evidence-Informed Ways to Support Better Health (2026)

Core Expertise Areas

Digital Reach & Professional Influence

Prof. Atanasov maintains one of the largest independent professional science audiences in biomedical and digital health fields:

LinkedIn: Active thought leader with a large global following of scientists, clinicians, and industry professionals
X (Twitter): Recognized voice in digital health, pharmacology, and research innovation
Bluesky: Emerging professional science communication presence
Combined audience: 165,000+ professionals across platforms

His audience profile spans academic researchers, healthcare professionals, biotech founders, investors, and science communicators — making him a uniquely effective partner for organizations seeking credible, targeted scientific outreach.

Engage Prof. Atanasov

Prof. Atanasov accepts a selective portfolio of consultancy mandates annually. Organizations and individuals seeking to engage him as a grant reviewer, investment evaluator, advisory board member, digital campaign partner, keynote speaker, or expert consultant are invited to reach out directly.

Relevant search terms for organizations and platforms seeking experts of this profile: